Validation of PARADISE 24 and Development of PARADISE-EDEN 36 in Patients with Dementia.
ICF
PARADISE-EDEN scale
dementia
functional state
long term care
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
06 06 2022
06 06 2022
Historique:
received:
30
04
2022
revised:
02
06
2022
accepted:
04
06
2022
entrez:
10
6
2022
pubmed:
11
6
2022
medline:
14
6
2022
Statut:
epublish
Résumé
Dementia was one of the conditions focused on in an EU (European Union) project called "PARADISE" (Psychosocial fActors Relevant to brAin DISorders in Europe) that later produced a measure called PARADISE 24, developed within the biopsychosocial model proposed in the International Classification of Functioning Disability and Health (ICF). The aims of this study are to validate PARADISE 24 on a wider sample of patients with mild to moderate dementia to expand PARADISE 24 by defining a more specific scale for dementia, by adding 18 questions specifically selected for dementia, which eventually should be reduced to 12. We enrolled 123 persons with dementia, recruited between July 2017 and July 2019 in home care and long-term care facilities, in Italy, and 80 participants were recruited in Warsaw between January and July 2012 as part of a previous cross-sectional study. The interviews with the patient and/or family were conducted by health professionals alone or as a team by using the Paradise data collection protocol. The psychometric analysis with the Rasch analysis has shown that PARADISE 24 and the selection of 18 additional condition-specific items can be expected to have good measurement properties to assess the functional state in persons with dementia.
Identifiants
pubmed: 35682531
pii: ijerph19116949
doi: 10.3390/ijerph19116949
pmc: PMC9180224
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Arthritis Rheum. 2007 Dec 15;57(8):1358-62
pubmed: 18050173
PLoS One. 2015 Sep 09;10(9):e0136271
pubmed: 26352911
Neurology. 1993 Feb;43(2):250-60
pubmed: 8094895
J Appl Meas. 2002;3(2):205-31
pubmed: 12011501
J Am Geriatr Soc. 1983 Dec;31(12):721-7
pubmed: 6418786
Int Psychogeriatr. 2014 Nov;26(11):1805-48
pubmed: 25096416
Am J Geriatr Psychiatry. 2019 Apr;27(4):363-377
pubmed: 30581140
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
Eur J Phys Rehabil Med. 2021 Aug;57(4):560-567
pubmed: 33258361
J Outcome Meas. 1998;2(1):66-78
pubmed: 9661732
Clin Interv Aging. 2014;9:105-10
pubmed: 24453481
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2007 Jul;50(7):924-31
pubmed: 17581728
PLoS One. 2015 Jul 06;10(7):e0132410
pubmed: 26147343
Dement Neuropsychol. 2020 Apr-Jun;14(2):93-102
pubmed: 32595877
J Appl Meas. 2003;4(3):205-21
pubmed: 12904672
BMJ Open. 2018 Sep 21;8(9):e024070
pubmed: 30244216
Bioinformatics. 2012 Jan 1;28(1):112-8
pubmed: 22039212
Curr Psychiatry Rep. 2017 May;19(5):25
pubmed: 28417268
Curr Psychiatry Rep. 2019 Sep 14;21(10):97
pubmed: 31522296
Alzheimer Dis Assoc Disord. 2011 Oct-Dec;25(4):289-304
pubmed: 21750453